EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CEACAM1 participation in breast cancer progression

Mykola Lyndin, Irina Kube-Golovin, Anatolii Romaniuk, Gunther Wennemuth iD

Molecular Oncology · 2026-11 · 20 (11) · 2805-2819

DOI: 10.1002/1878-0261.70306 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Oncology, online erschienen am 10.07.2026. Verfasst von Mykola Lyndin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, University Hospital Essen, Essen, Germany. Hauptthemen laut MEDLINE: Breast Neoplasms, CEACAM1 Protein, Disease Progression, Cell Adhesion Molecules. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carcinoembryonic antigen‐related cell adhesion molecule 1 (CEACAM1) is widely expressed in human cells and undergoes marked alterations during tumorigenesis. However, its functional significance in invasive breast cancer (BC) remains insufficiently understood. In this study, CEACAM1 expression patterns in invasive BC tissues were analyzed and correlated with the proliferative index (PI) of the tumor cells. To assess isoform‐specific functional effects and identify CEACAM1‐responsive genes involved in key proliferation‐associated pathways, MCF‐7 cells were transfected with either CEACAM1 short cytoplasmic domain isoform (CEACAM1‐4S) or CEACAM1 long cytoplasmic domain isoform (CEACAM1‐4L). BC tissues exhibited substantial heterogeneity in CEACAM1 expression, which correlated with the PI of the tumor cells. Functional in vitro studies demonstrated that the CEACAM1‐4L isoform exclusively suppresses cell proliferation. Transcriptome and protein‐level analyses revealed that CEACAM1‐4L regulates the expression of key mediators involved in cell cycle control, apoptosis, extracellular matrix organization, and growth factor‐dependent signaling pathways. These findings highlight the biological significance of CEACAM1‐4L isoform in BC, its potential diagnostic relevance for patient stratification, as well as its possible consideration in future therapeutic approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCEACAM1 ProteinDisease ProgressionCell Adhesion MoleculesHumansFemaleCell ProliferationGene Expression Regulation, NeoplasticProtein IsoformsMCF-7 CellsSignal TransductionApoptosisAntigens, CD

Stichwörter der Autor:innen

CEACAM1CEACAM1‐4Lbreast cancercell proliferationtumor progression

Substanzen

CEACAM1 ProteinProtein IsoformsCD66 antigensCell Adhesion MoleculesAntigens, CD

Autor:innen und Institutionen

  • Department of Anatomy, University Hospital Essen, Essen, Germany.
  • Department of Pathology, Academic and Research Medical Institute, Sumy State University, Sumy, Ukraine.

ORCID-Profile: Gunther Wennemuth

Zitieren

APA

Lyndin, M., Kube-Golovin, I., Romaniuk, A., & Wennemuth, G. (2026). CEACAM1 participation in breast cancer progression. Molecular Oncology, 20(11), 2805-2819. https://doi.org/10.1002/1878-0261.70306

Vancouver

Lyndin M, Kube-Golovin I, Romaniuk A, Wennemuth G. CEACAM1 participation in breast cancer progression. Molecular Oncology. 2026;20(11):2805-2819. doi:10.1002/1878-0261.70306

BibTeX
@article{Lyndin2026,
  author = {Lyndin, Mykola and Kube-Golovin, Irina and Romaniuk, Anatolii and Wennemuth, Gunther},
  title = {CEACAM1 participation in breast cancer progression},
  journal = {Molecular Oncology},
  year = {2026},
  volume = {20},
  number = {11},
  pages = {2805--2819},
  doi = {10.1002/1878-0261.70306}
}
Kostenlos starten →